|
|
|
Corporate Profile: Resverlogix
| Summary: |
Resverlogix is focused on the research and development of treatments for patients with cardiovascular disorders us an epigenetic technology that modulates protein production.
|
| Address (HQ): |
300, 4820 Richard Road SW
Calgary, AB T3E 6L1
Canada |
| Phone
#'s (HQ): |
| Main |
(403) 254-9252 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s (HQ): |
| Main |
(403) 256-8495 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications mentioning company on PubMed: publications
link. |
|
|
|
